Nexgel Inc Stock Cash And Equivalents
| NXGL Stock | USD 2.12 0.02 0.95% |
Nexgel Inc fundamentals help investors to digest information that contributes to Nexgel's financial success or failures. It also enables traders to predict the movement of Nexgel Stock. The fundamental analysis module provides a way to measure Nexgel's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nexgel stock.
Nexgel | Cash And Equivalents |
Nexgel Inc Company Cash And Equivalents Analysis
Nexgel's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Nexgel Cash And Equivalents | 9.79 M |
Most of Nexgel's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nexgel Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Nexgel Cash And Equivalents Driver Correlations
Understanding the fundamental principles of building solid financial models for Nexgel is extremely important. It helps to project a fair market value of Nexgel Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since Nexgel's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nexgel's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nexgel's interrelated accounts and indicators.
Click cells to compare fundamentals
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, Nexgel Inc has 9.79 M in Cash And Equivalents. This is 98.81% lower than that of the Health Care Equipment & Supplies sector and 96.88% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 99.64% higher than that of the company.
Nexgel Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nexgel's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nexgel could also be used in its relative valuation, which is a method of valuing Nexgel by comparing valuation metrics of similar companies.Nexgel is currently under evaluation in cash and equivalents category among related companies.
Nexgel Current Valuation Drivers
We derive many important indicators used in calculating different scores of Nexgel from analyzing Nexgel's financial statements. These drivers represent accounts that assess Nexgel's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Nexgel's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 47.8M | 367.1M | 14.5M | 7.0M | 12.1M | 11.5M | |
| Enterprise Value | 48.4M | 368.3M | 5.5M | 8.0M | 12.2M | 11.6M |
Nexgel Fundamentals
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.21 | ||||
| Profit Margin | (0.77) % | ||||
| Operating Margin | (1.43) % | ||||
| Current Valuation | 13.65 M | ||||
| Shares Outstanding | 6.23 M | ||||
| Shares Owned By Insiders | 22.82 % | ||||
| Shares Owned By Institutions | 2.22 % | ||||
| Number Of Shares Shorted | 17.72 K | ||||
| Price To Book | 2.89 X | ||||
| Price To Sales | 3.32 X | ||||
| Revenue | 4.09 M | ||||
| Gross Profit | 256 K | ||||
| EBITDA | (3.03 M) | ||||
| Net Income | (3.16 M) | ||||
| Cash And Equivalents | 9.79 M | ||||
| Cash Per Share | 1.76 X | ||||
| Total Debt | 2.8 M | ||||
| Debt To Equity | 0.36 % | ||||
| Current Ratio | 4.33 X | ||||
| Book Value Per Share | 0.82 X | ||||
| Cash Flow From Operations | (3.24 M) | ||||
| Short Ratio | 0.75 X | ||||
| Earnings Per Share | (0.56) X | ||||
| Target Price | 6.0 | ||||
| Number Of Employees | 19 | ||||
| Beta | 0.68 | ||||
| Market Capitalization | 13.08 M | ||||
| Total Asset | 9.96 M | ||||
| Retained Earnings | (14.71 M) | ||||
| Working Capital | 2.5 M | ||||
| Net Asset | 9.96 M |
About Nexgel Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nexgel Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nexgel using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nexgel Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Nexgel in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Nexgel's short interest history, or implied volatility extrapolated from Nexgel options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Nexgel Piotroski F Score and Nexgel Altman Z Score analysis. Note that the Nexgel Inc information on this page should be used as a complementary analysis to other Nexgel's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Nexgel Stock analysis
When running Nexgel's price analysis, check to measure Nexgel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nexgel is operating at the current time. Most of Nexgel's value examination focuses on studying past and present price action to predict the probability of Nexgel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nexgel's price. Additionally, you may evaluate how the addition of Nexgel to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is Nexgel's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. If investors know Nexgel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexgel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.56) | Revenue Per Share 0.721 | Quarterly Revenue Growth 1.065 | Return On Assets (0.21) | Return On Equity (0.50) |
The market value of Nexgel Inc is measured differently than its book value, which is the value of Nexgel that is recorded on the company's balance sheet. Investors also form their own opinion of Nexgel's value that differs from its market value or its book value, called intrinsic value, which is Nexgel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexgel's market value can be influenced by many factors that don't directly affect Nexgel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexgel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexgel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexgel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.